Chin Sang C, Moore G, Tereshchenko M, Zhang H, Nosella M, Dasovich M
EMBO Rep. 2024; 25(12):5635-5666.
PMID: 39496836
PMC: 11624282.
DOI: 10.1038/s44319-024-00285-5.
Sukhanova M, Anarbaev R, Maltseva E, Kutuzov M, Lavrik O
Commun Biol. 2024; 7(1):1148.
PMID: 39278937
PMC: 11402994.
DOI: 10.1038/s42003-024-06811-4.
Al-Rahahleh R, Sobol R
Environ Mol Mutagen. 2024; 65(9):315-337.
PMID: 39221603
PMC: 11604531.
DOI: 10.1002/em.22623.
Jiang K, Wang Q, Chen X, Wang X, Gu X, Feng S
Int J Nanomedicine. 2024; 19:8847-8882.
PMID: 39220190
PMC: 11366248.
DOI: 10.2147/IJN.S458086.
Huang M, Zhu X, Wang C, He L, Li L, Wang H
Cell Death Dis. 2024; 15(8):610.
PMID: 39174499
PMC: 11341912.
DOI: 10.1038/s41419-024-07009-6.
General ADP-Ribosylation Mechanism Based on the Structure of ADP-Ribosyltransferase-Substrate Complexes.
Tsuge H, Habuka N, Yoshida T
Toxins (Basel). 2024; 16(7).
PMID: 39057953
PMC: 11281641.
DOI: 10.3390/toxins16070313.
Full-length GSDME mediates pyroptosis independent from cleavage.
Zhou B, Jiang Z, Dai M, Ai Y, Xiao L, Zhong C
Nat Cell Biol. 2024; 26(9):1545-1557.
PMID: 38997456
DOI: 10.1038/s41556-024-01463-2.
Chemical tools for profiling the intracellular ADP-ribosylated proteome.
Draganov S, Gruet M, Conole D, Balcells C, Siskos A, Keun H
RSC Chem Biol. 2024; 5(7):640-651.
PMID: 38966672
PMC: 11221532.
DOI: 10.1039/d4cb00043a.
[F]F-Poly(ADP-Ribose) Polymerase Inhibitor Radiotracers for Imaging PARP Expression and Their Potential Clinical Applications in Oncology.
Ndlovu H, Lawal I, Mdanda S, Kgatle M, Mokoala K, Al-Ibraheem A
J Clin Med. 2024; 13(12).
PMID: 38929955
PMC: 11204862.
DOI: 10.3390/jcm13123426.
Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
Zentout S, Imburchia V, Chapuis C, Duma L, Schutzenhofer K, Prokhorova E
Proc Natl Acad Sci U S A. 2024; 121(25):e2322689121.
PMID: 38865276
PMC: 11194589.
DOI: 10.1073/pnas.2322689121.
Low magnesium in conjunction with high homocysteine increases DNA damage in healthy middle aged Australians.
Dhillon V, Deo P, Fenech M
Eur J Nutr. 2024; 63(7):2555-2565.
PMID: 38864865
PMC: 11490467.
DOI: 10.1007/s00394-024-03449-0.
CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer.
Acharya G, Mani C, Sah N, Saamarthy K, Young R, Reedy M
Cell Death Discov. 2024; 10(1):278.
PMID: 38862485
PMC: 11166985.
DOI: 10.1038/s41420-024-02040-0.
DePARylation is critical for S phase progression and cell survival.
Nie L, Wang C, Huang M, Liu X, Feng X, Tang M
Elife. 2024; 12.
PMID: 38578205
PMC: 10997334.
DOI: 10.7554/eLife.89303.
Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.
Ndlovu H, Lawal I, Mokoala K, Sathekge M
Int J Mol Sci. 2024; 25(3).
PMID: 38338854
PMC: 10855575.
DOI: 10.3390/ijms25031575.
PARP1 condensates differentially partition DNA repair proteins and enhance DNA ligation.
Chin Sang C, Moore G, Tereshchenko M, Nosella M, Zhang H, Alderson T
bioRxiv. 2024; .
PMID: 38328070
PMC: 10849519.
DOI: 10.1101/2024.01.20.575817.
Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1.
Bacic L, Gaullier G, Mohapatra J, Mao G, Brackmann K, Panfilov M
Nat Commun. 2024; 15(1):1000.
PMID: 38307862
PMC: 10837151.
DOI: 10.1038/s41467-024-45237-8.
Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage.
Al-Rahahleh R, Saville K, Andrews J, Wu Z, Koczor C, Sobol R
bioRxiv. 2024; .
PMID: 38234836
PMC: 10793466.
DOI: 10.1101/2023.12.29.573650.
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
Geng L, Zhu M, Luo D, Chen H, Li B, Lao Y
Oncogene. 2024; 43(9):682-692.
PMID: 38216672
PMC: 10890932.
DOI: 10.1038/s41388-023-02935-9.
The recruitment of ACF1 and SMARCA5 to DNA lesions relies on ADP-ribosylation dependent chromatin unfolding.
Pinto Jurado E, Smith R, Bigot N, Chapuis C, Timinszky G, Huet S
Mol Biol Cell. 2024; 35(3):br7.
PMID: 38170578
PMC: 10916859.
DOI: 10.1091/mbc.E23-07-0281.
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in -mutated cancer.
Li P, Zhen Y, Kim C, Liu Z, Hao J, Deng H
Sci Adv. 2023; 9(43):eadg7752.
PMID: 37878693
PMC: 10599614.
DOI: 10.1126/sciadv.adg7752.